AstraZeneca Group (AZN)
AstraZeneca Group Cash Flow
- Quarterly: March 2012 - December 2009 Previous Quarters
- Annual
| Cash Flow - Operations | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 | 2010-09 | 2010-06 | 2010-03 | 2009-12 |
| Net Income | 2.053B | 2.052B | 4.169B | 2.858B | 3.288B | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Depreciation, Depletion, Amortization | 499.00M | 970.00M | 543.00M | 511.00M | 526.00M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Other Non-Cash Items | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Total Non-Cash Items | 499.00M | 970.00M | 543.00M | 511.00M | 526.00M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Deferred Income Taxes | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Total Changes in Assets/Liabilities | 364.00M | 631.00M | -475.00M | -189.00M | -864.00M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Other Operating Activities | -1.376B | -584.00M | -2.314B | -2.241B | -1.06B | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Net Cash from Operating Activities | 1.54B | 3.069B | 1.923B | 939.00M | 1.89B | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Cash Flow - Investing | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 | 2010-09 | 2010-06 | 2010-03 | 2009-12 |
| Capital Expenditures | 3.00M | -200.00M | -202.00M | -198.00M | -137.00M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Acquisitions, Divestitures | 0.00 | 16.00M | 1.756B | 0.00 | 0.00 | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Investments | 649.00M | -3.288B | -312.00M | 530.00M | 316.00M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Other Investing Activities | -59.00M | -108.00M | 30.00M | -146.00M | -79.00M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Cash Flow - Financing | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 | 2010-09 | 2010-06 | 2010-03 | 2009-12 |
| Net Cash from Investing Activities | 593.00M | -3.58B | 1.272B | 186.00M | 100.00M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Debt Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Equity Issued | -912.00M | -1.728B | -1.674B | -993.00M | -1.211B | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Dividends Paid | -2.505B | 0.00 | -1.118B | 0.00 | -2.646B | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Other Financing Activities | 13.00M | 0.00 | 9.00M | -47.00M | 41.00M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Net Cash from Financing Activities | -3.438B | -1.681B | -2.803B | -1.03B | -3.807B | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Foreign Exchange Effects | 14.00M | 5.00M | -70.00M | 10.00M | 30.00M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Net Change in Cash & Cash Equivalents | -1.291B | -2.187B | 322.00M | 105.00M | -1.787B | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Cash at beginning of period | 7.434B | 10.98B | 7.434B | 9.621B | 9.299B | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Cash at end of period | 6.143B | 7.434B | 9.621B | 9.299B | 9.194B | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
